The_DT
peroxisome_NN
proliferator-activated_JJ
receptor_NN
alpha_NN
-LRB-_-LRB-
PPARalpha_NN
-RRB-_-RRB-
ligand_NN
WY_NN
14,643_NN
does_VBZ
not_RB
interfere_VB
with_IN
leukotriene_NN
B4_NN
induced_VBN
adhesion_NN
of_IN
neutrophils_NNS
to_TO
endothelial_JJ
cells_NNS
._.

Peroxisome_NN
proliferator-activated_JJ
receptors_NNS
-LRB-_-LRB-
PPAR_NN
-RRB-_-RRB-
control_VBP
discrete_JJ
genes_NNS
involved_VBN
in_IN
fatty_JJ
acid_NN
and_CC
lipid_NN
metabolism_NN
._.

Recently_RB
,_,
it_PRP
was_VBD
suggested_VBN
that_IN
activation_NN
of_IN
the_DT
alpha_NN
isoform_NN
of_IN
PPAR_NN
by_IN
the_DT
potent_JJ
proinflammatory_JJ
mediator_NN
leukotriene_NN
B4_NN
-LRB-_-LRB-
LTB4_NN
-RRB-_-RRB-
enhanced_VBD
degradation_NN
of_IN
this_DT
eicosanoid_NN
,_,
offersuggesting_VBG
a_DT
new_JJ
aspect_NN
of_IN
down-regulation_NN
of_IN
inflammation_NN
._.

Here_RB
,_,
we_PRP
studied_VBD
whether_IN
PPARalpha_NN
activation_NN
-LRB-_-LRB-
by_IN
means_NNS
of_IN
the_DT
selective_JJ
agonist_NN
WY_NN
14,643_CD
-RRB-_-RRB-
of_IN
endothelial_JJ
cells_NNS
,_,
pivotal_JJ
in_IN
the_DT
regulation_NN
of_IN
inflammatory_JJ
responses_NNS
,_,
interfered_VBN
with_IN
LTB4_NN
induced_VBD
adhesion_NN
of_IN
PMN_NN
neutrophil_NN
granulocytes_NNS
in_FW
vitro_FW
._.

When_WRB
endothelial_JJ
cells_NNS
were_VBD
treated_VBN
with_IN
WY_NN
14,643_CD
prior_JJ
to_TO
activation_NN
with_IN
LTB4_NN
-LRB-_-LRB-
or_CC
fMLP_NN
,_,
IL-1beta_NN
or_CC
TNFalpha_NN
,_,
as_IN
controls_NNS
-RRB-_-RRB-
we_PRP
could_MD
not_RB
document_VB
any_DT
effect_NN
on_IN
the_DT
number_NN
of_IN
adhering_JJ
PMN_NN
or_CC
duration_NN
of_IN
the_DT
response_NN
._.

Thus_RB
,_,
this_DT
study_NN
provides_VBZ
no_DT
evidence_NN
indicating_VBG
a_DT
regulatory_JJ
function_NN
of_IN
PPARalpha_NN
in_IN
LTB4_NN
induced_VBN
adhesive_JJ
interactions_NNS
between_IN
endothelial_JJ
cells_NNS
and_CC
neutrophils_NNS
._.

